NA

Helping healthcare professionals to support patients


The updated Shingles Immunisation Programme one year on: What have we learnt?

This is a promotional webinar organised and funded by GSK for UK Healthcare professionals and other relevant decision makers only. This includes paid speaker(s).

Prescribing Information GB & NI

Adverse event reporting statement is at the foot of this page.

Join our expert-led webinars on 10th September at 18:30 or 12th September at 13:00 where we will be discussing best practice tips from one year of the updated Shingles Immunisation Programme.

August 2024 | PM-GB-SGX-WCNT-240026 (V1.0)

Featured products

Links to prescribing information at bottom of page.

More resources

Get more from GSKpro

Get access to free patient resources including demo devices, exclusive webinars on the topics that matter to you and more.

Prescribing information

Trelegy Ellipta prescribing information

Nucala prescribing information

Zejula prescribing information (GB)

Zejula prescribing information (NI)

SHINGRIX prescribing information (GB)

SHINGRIX prescribing information (NI)

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellowcard in the Google Play or Apple App Store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com.

June 2024 | PM-GB-NA-WCNT-210014 (V9.0)